Literature DB >> 125419

Biological properties of plasmin digests of S-carbamidomethylated human growth hormone.

C R Reagan, J B Mills, J L Kostyo, A E Wilhelmi.   

Abstract

Reduction and carbamidomethylation of the intrachain disulfide bridges of human growth hormone did not destroy its ability to stimulate weight gain or cartilage metabolism in hypophysectomized rats. The reduced and alkylated hormone also stimulated glucose oxidation in isolated adipose tissue of hypophysectomized rats when added in vitro. When the S-carbamidomethylated hormone was incubated overnight with human plasmin, approximately 95% of the starting material was completely digested, as judged by polyacrylamide gel electrophoresis. The plasmin digest retained the ability to stimulate weight gain, cartilage metabolism, and glucose oxidation. A fraction consisting of two major electrophoretic components was isolated from the digest by chromatography on tsephadex G-50. This fraction possessed the biological properties of the whole digest.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 125419      PMCID: PMC432608          DOI: 10.1073/pnas.72.5.1684

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  7 in total

1.  DISC ELECTROPHORESIS. I. BACKGROUND AND THEORY.

Authors:  L ORNSTEIN
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  Further studies on the fractionation of human pituitary glands.

Authors:  A F Parlow; A E Wilhelmi; L E Reichert
Journal:  Endocrinology       Date:  1965-12       Impact factor: 4.736

3.  Retention of the biological potency of human pituitary growth hormone after reduction and carbamidomethylation.

Authors:  J S Dixon; C H Li
Journal:  Science       Date:  1966-11-11       Impact factor: 47.728

4.  Retention of biologic activity of human growth hormone in man after reduction and alkylation.

Authors:  M H Connors; S L Kaplan; C H Li; M M Grumbach
Journal:  J Clin Endocrinol Metab       Date:  1973-10       Impact factor: 5.958

5.  Some metabolic changes induced by acute administration of native and reduced-tetra-S-carbamidomethylated human growth hormone in man.

Authors:  E Cerosi; C H Li; R Luft
Journal:  J Clin Endocrinol Metab       Date:  1972-04       Impact factor: 5.958

6.  Human pituitary growth hormone: isolation and properties of two biologically active fragments from plasmin digests.

Authors:  C H Li; L Gráf
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

7.  Metabolic effects of plasmin digests of human growth hormone in the rat and man.

Authors:  J B Mills; C R Reagan; D Rudman; J L Kostyo; P Zachariah; A E Wilhelmi
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

  7 in total
  5 in total

1.  Rate of concentration and digestion of radioactive growth hormone preparations injected in rats, as measured by the amount and nature of radioactivity in the tissues.

Authors:  L A Retegui-Sardou; L O Scaramal; J M Dellacha; A C Paladini
Journal:  Mol Cell Biochem       Date:  1977-07-05       Impact factor: 3.396

2.  Activity of human growth hormone and related polypeptides on the adipose conversion of 3T3 cells.

Authors:  M Morikawa; H Green; U J Lewis
Journal:  Mol Cell Biol       Date:  1984-02       Impact factor: 4.272

3.  Human pituitary growth hormone: a biologically active hendekakaihekaton peptide fragment corresponding to amino-acid residues 15-125 in the hormone molecule.

Authors:  C H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

4.  Diabetogenic peptide from human growth hormone: partial purification from peptic digest and long-term action in ob/ob mice.

Authors:  A J Lostroh; M E Krahl
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

5.  Anabolic actions of reduced and S-carbamidomethylated human growth hormone and its plasmin digest in man.

Authors:  S B Heymsfield; R A Bethel; E C Hall; J B Mills; M H Moseley; J L Kostyo; D Rudman
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.